MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium
9/28/2012 10:41:31 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)
6/20/2012 11:47:28 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV)
4/24/2012 9:10:37 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Begins Phase 1 Trial of MDT-637 for Treatment of Respiratory Syncytial Virus
9/27/2011 10:40:52 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning
6/7/2011 8:39:11 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Achievement of Development Milestone Triggering a Payment Under Respiratory Collaboration
5/2/2011 9:15:13 AM
More...
|
Gilead Sciences, Inc. (GILD), MicroDose Therapeutx (formerly MicroDose Technologies Inc) Ink License Deal For MDT-637
4/20/2011 8:18:53 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Nexus6 Announce Worldwide Partnership to Commercialize the SmartInhalerLiveTM Technology with MicroDose's Electronic Dry Powder Inhalers
11/9/2010 11:11:30 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Awarded Four Therapeutic Discovery Grants Totaling Approximately $1 Million
11/4/2010 10:59:45 AM
More...
|
MicroDose Therapeutx (formerly MicroDose Technologies Inc) to Present at the 30th Annual Cowen and Company Healthcare Conference on Tuesday, March 9th
3/4/2010 9:44:41 AM
More...
|
|